
Kuvan® (sapropterin dihydrochloride) is indicated in conjunction with a Phe-restricted diet to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to …
• The recommended starting dose of Kuvan is 10 mg/kg taken once daily. • Response to Kuvan is determined by change in blood Phe following treatment with Kuvan at 10 mg/kg/day for a …
Kuvan: Uses, Dosage, Side Effects, Warnings - Drugs.com
Aug 22, 2023 · Kuvan (sapropterin) is used along with a restricted diet to control blood phenylalanine levels in adults and children one month of age and older who have …
KUVAN Homepage | Prescription Medication for PKU
KUVAN ® (sapropterin dihydrochloride) Tablets for Oral Use and Powder for Oral Solution are prescription medicines used to lower blood Phe levels in adults and children over one month of …
Kuvan - European Medicines Agency (EMA)
Kuvan is indicated for the treatment of hyperphenylalaninaemia (HPA) in adults and paediatric patients of all ages with phenylketonuria (PKU) who have been shown to be responsive to …
Kuvan: Uses, Taking, Side Effects, Warnings - Medicine.com
Kuvan is a prescription medicine used to lower blood levels of phenylalanine (Phe), in adults and children one month of age and older with a certain type of Phenylketonuria (PKU). Kuvan is …
Kuvan is a phenylalanine hydroxylase activator indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients one month of age and older with hyperphenylalaninemia …
Kuvan - summary of medicine characteristics - Patient info
Kuvan is indicated for the treatment of hyperphenylalaninaemia (HPA) in adults and paediatric patients of all ages with phenylketonuria (PKU) who have been shown to be responsive to …
Patient Information | KUVAN
KUVAN ® (sapropterin dihydrochloride) Tablets for Oral Use and Powder for Oral Solution are prescription medicines used to lower blood Phe levels in adults and children over one month of …
Kuvan is a phenylalanine hydroxylase activator indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) …
- Some results have been removed